4 documents found, page 1 of 1
CARDIAC SURGERY IN PATIENTS WITH DIALYSIS-DEPENDENT END STAGE RENAL FAILURE: SI...
Ranchordas, Sara; Madeira, Márcio; Pereira, Tiago; Branco, Patrícia; Gaspar, Augusta; Marques, Marta; Calquinha, José; Abecasis, Miguel; Neves, José P.Background: Patients under dialysis have a high cardiovascular risk and they are at increased risk when submitted to cardiac surgery. Aim of the study: to evaluate morbidity, early and late mortality, and predictive factors of mortality in patients under dialysis who underwent cardiac surgery. Methods: A retrospective observational study was performed including all dialysis dependent patients who underwent card...
COLD AGGLUTININS AND CARDIAC SURGEY: A CASE REPORT
Magro, Pedro; Marques, Sofia; Calquinha, José; Neves, José PedroCold agglutinins (CA) are autoantibodies whose clinical significance depends upon titer and thermal amplitude. Patients, which undergo cardio-pulmonary bypass and especially hypothermic cardioplegia myocardial protection, represent a challenge regarding operative management, as tissue temperature should be maintained above the threshold of agglutination. We report on a case in which the presence of CA was disco...
INFERIOR VENA CAVA STENTING AFTER CARDIAC MYXOMA EXCISION
Magro, Pedro; Abecasis, João; Calquinha, José; Neves, JoséA 63-years-old female developed shock after cardiac myxoma excision. Echocardiography identified inferior vena cava (IVC) stenosis and re-intervention with atrial and septal patch augmentation was attempted. The patient maintained hemodynamic instability as well as high IVC gradient and intraluminal thrombus. IVC percutaneous stenting was achieved and enabled full hemodynamic recovery.
LEFT SUPERIOR VENA CAVA INCIDENTAL FINDING DURING PACEMAKER IMPLANTATION AFTER ...
Magro, Pedro; Boshoff, Sérgio; Calquinha, JoséA 68-year-old female presents with AV block after mitral repair surgery. Persistent left superior vena cava (PLSVC) was diagnosed during double chamber pacemaker implantation. PLSVC has a prevalence of 0.3-0.5% and may render cardiopulmonary bypass and device implantation more challenging. Nevertheless, evidence suggests it does not influence long-term follow-up.